Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8750816 | Respiratory Investigation | 2017 | 10 Pages |
Abstract
These variations in the clinical course and comorbidities have affected the researchers' and physicians' understanding of IPF. Therefore, better identification and understanding of these variations may be helpful when making decisions regarding therapeutic interventions. Furthermore, the identification and treatment of comorbidities may have a clinically significant impact on patient survival. Future studies should use well-established definitions for distinct progression patterns and comorbid conditions to obtain greater insights into the pathogenesis and treatment of IPF.
Keywords
DLIUCTDmPAPUIPPPFEAcute exacerbation of idiopathic pulmonary fibrosisNSIPHRCTIIPsCPAPRHCaHIBALFVCACSIPFIPAFCTDCPFEILDDrug-induced lung injuryobstructive sleep apneaOsaConnective tissue diseaseInterstitial lung diseasecoronary artery diseaseChronic obstructive pulmonary diseaseCOPDDVTDeep-vein thrombosisAcute exacerbationshigh-resolution computed tomographyGERGastroesophageal refluxLung cancerNSCLCNon-small cell lung cancerAcute coronary syndromeapnea-hypopnea indexCADforced vital capacityconfidence intervalContinuous positive airway pressuremean pulmonary artery pressurePleuroparenchymal fibroelastosisidiopathic pulmonary fibrosisCombined pulmonary fibrosis and emphysemabronchoalveolar lavagehazard ratioodds ratioRate RatioComorbiditiesPulmonary hypertensioninterstitial pneumonia with autoimmune featuresUsual interstitial pneumoniaNonspecific interstitial pneumoniaIdiopathic interstitial pneumoniasDisease progressionRight heart catheterization
Related Topics
Life Sciences
Immunology and Microbiology
Immunology and Microbiology (General)
Authors
Atsushi Suzuki, Yasuhiro Kondoh,